STERIS (STE) Director Pierre Boulud Receives RSU Award

What Happened Pierre Boulud, a director of STERIS plc, was granted 1,025 Career Restricted Stock Units (transaction code A) on 2026-08-10. The award is recorded at $0.00 at grant (derivative award) and will be settled in STERIS ordinary shares per the filing. This is an equity award (not a purchase or sale) as part of director compensation.

Key Details

• Transaction date: 2026-08-10; Filing date: 2026-08-12 (appears timely).
• Award: 1,025 Career Restricted Stock Units (price shown $0.00; derivative).
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1: Each Career Restricted Stock Unit equals the right to receive one STERIS ordinary share six months after the cessation of the director’s Board service.
  • F2: These Career RSUs are fully vested immediately and will be settled in ordinary shares six months after the director stops serving on the Board.
• No indication of a 10b5-1 plan, tax withholding, or late filing in this Form 4.

Context These Career RSUs are a deferred settlement equity award: they vest now but convert to actual shares only six months after Boulud leaves the Board, so they are not an immediate market purchase or sale and do not directly signal a near-term trading decision. Director RSU grants are commonly used as compensation and retention tools.